The clinical utility of polygenic risk scores for chronic lymphocytic leukemia

Leukemia. 2021 Dec;35(12):3608-3610. doi: 10.1038/s41375-021-01429-5. Epub 2021 Sep 25.

Authors

Amit Sud^{1

2}, Philip J Law³, Richard S Houlston³

Affiliations

¹ Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. amit.sud@icr.ac.uk.
² Department of Haemato-Oncology, The Royal Marsden Hospital NHS Foundation Trust, London, UK. amit.sud@icr.ac.uk.
³ Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Genome-Wide Association Study
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
Leukemia, Lymphocytic, Chronic, B-Cell / pathology
Multifactorial Inheritance*
ROC Curve
Risk Factors

Grants and funding